Cargando…
Circulating TGF-β1 and VEGF and risk of cancer among liver transplant recipients
Transplant recipients have elevated cancer risk, perhaps partly due to direct carcinogenic effects of immunosuppressive medications. Experimental evidence indicates that calcineurin inhibitors given to transplant recipients increase cellular expression of transforming growth factor β1 (TGF-β1) and v...
Autores principales: | Engels, Eric A, Jennings, Linda, Kemp, Troy J, Chaturvedi, Anil K, Pinto, Ligia A, Pfeiffer, Ruth M, Trotter, James F, Acker, Michelle, Onaca, Nicholas, Klintmalm, Goran B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559036/ https://www.ncbi.nlm.nih.gov/pubmed/25919050 http://dx.doi.org/10.1002/cam4.455 |
Ejemplares similares
-
Donor-specific Antibodies, Immunoglobulin-free Light Chains, and BAFF Levels in Relation to Risk of Late-onset PTLD in Liver Recipients
por: Engels, Eric A., et al.
Publicado: (2018) -
Belatacept Treatment of Recurrent Late-onset T Cell–mediated Rejection/Antibody-mediated Rejection With De Novo Donor-specific Antibodies in a Liver Transplant Patient
por: Klintmalm, Göran B., et al.
Publicado: (2022) -
Associations between self-reported diabetes and 78 circulating markers of inflammation, immunity, and metabolism among adults in the United States
por: Van Dyke, Alison L., et al.
Publicado: (2017) -
KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D
por: Jha, Sawan Kumar, et al.
Publicado: (2019) -
HCK promotes glioblastoma progression by TGFβ signaling
por: Wang, Zhenlin, et al.
Publicado: (2020)